Fine Needle Aspiration Biopsy Case Volumes: A Two-year Analysis of FNA biopsy Diagnostic Categories During the COVID-19 Pandemic

Chen, Chang; Nguyen, Kimtuyen; Wiles, Austin; Sayeed, Sadia

doi:10.1016/j.jasc.2021.07.106

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We performed a naso-pharyngeal swab the day before the procedure and administered a health questionnaire the day of the procedure before admitting the patient to the radiology department. Our safety protocol was similar to those already reported in literature for other purpose and produced the same results: the rate of collateral diagnosis of suspected COVID infection during the control scan of the procedure was very low (only one patient) and comparable to those reported (0.2%) [15,16]. It is interesting that the rate of procedures cancelled or postponed (14%) was significantly lower than that reported for lung cancer screening (32.7%) probably due to the different nature of the examinations (voluntary nature of the screening compared to the potentially disruptive results of the diagnostic biopsy procedure).…”

Section: Resultssupporting

confidence: 82%

CT Scan-Guided Fine Needle Aspiration Cytology for Lung Cancer Diagnosis through the COVID-19 Pandemic: What We Have Learned

et al. 2023

View full text Add to dashboard Cite

Background and rationale. Novel coronavirus-related disease (COVID-19) has profoundly influenced hospital organization and structures worldwide. In Italy, the Lombardy Region, with almost 17% of the Italian population, rapidly became the most severely affected area since the pandemic beginning. The first and the following COVID-19 surges significantly affected lung cancer diagnosis and subsequent management. Much data have been already published regarding the therapeutic repercussions whereas very few reports have focused on the consequences of the pandemic on diagnostic procedures. Methods. We, here, would like to analyze data of novel lung cancer diagnosis performed in our Institution in Norther Italy where we faced the earliest and largest outbreaks of COVID-19 in Italy. Results. We discuss, in detail, the strategies developed to perform biopsies and the safe pathways created in emergency settings to protect lung cancer patients in subsequent therapeutic phases. Quite unexpectedly, no significant differences emerged between cases enrolled during the pandemic and those before, and the two populations were homogeneous considering the composition and diagnostic and complication rates. Conclusions. By pointing out the role of multidisciplinarity in emergency contexts, these data will be of help in the future for designing tailored strategies to manage lung cancer in a real-life setting.

show abstract

Section: Resultssupporting

confidence: 82%